Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Blame Covid

<< Previous

Bullboard Posts

Next >>

Post by Domino55on Mar 11, 2022 10:27am

117 Views

Post# 34506419

Blame Covid

Covid apparently slowed down recruitment

Slow recruitment allegedly led to the 42 cent financing

The 42 cent financing led to all time low share prices

All time low share prices allowed for the opportunity for maximum options barely above these all time lows

Of course the backdrop to this is significant advancement in both PMX and Dialco, along with minimal communication to shareholders. Somehow Covid has affected communication strategy.

Blame Covid

<< Previous

Bullboard Posts

Next >>

B2Gold stock buckles under news of labour strike in Mali